Cargando…

Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray

A rapid, convenient, and sensitive analytical technique for quantitative analysis of triamcinolone acetonide (TAC) in pharmaceutical nasal spray dosage form using the blue tetrazolium colorimetric reaction and UV spectrophotometric method was developed and validated. Beer’s law of the developed meth...

Descripción completa

Detalles Bibliográficos
Autores principales: Alzeer, Haya S., Alzaid, Shikah F., Aldawsari, Fahad S., Alshehri, Yahya M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542632/
https://www.ncbi.nlm.nih.gov/pubmed/37791036
http://dx.doi.org/10.1016/j.jsps.2023.101793
_version_ 1785114133060911104
author Alzeer, Haya S.
Alzaid, Shikah F.
Aldawsari, Fahad S.
Alshehri, Yahya M.
author_facet Alzeer, Haya S.
Alzaid, Shikah F.
Aldawsari, Fahad S.
Alshehri, Yahya M.
author_sort Alzeer, Haya S.
collection PubMed
description A rapid, convenient, and sensitive analytical technique for quantitative analysis of triamcinolone acetonide (TAC) in pharmaceutical nasal spray dosage form using the blue tetrazolium colorimetric reaction and UV spectrophotometric method was developed and validated. Beer’s law of the developed method was proven in the concentration range of 10–40 µg/mL and showed a specific linear relationship with coefficient value R2 = 0.998. The LOQ level was 9.99 µg/mL, with (RSD = 0.26%). From precision assay, RSD values have been obtained for the repeatability and intermediate precision, which were found to be (RSD = 1.65%) and (RSD = 2.01%), respectively, indicating that the method is reproducible. Recovery studies showed mean recoveries in the range of (100.08–103.65 %), meeting the acceptance criteria for accuracy. In addition, we compared the results of the developed method UV–Vis spectrophotometric procedure with those of a well-established official USP analytical procedure (HPLC), and the results showed good agreement. The proposed UV method represents a potential alternative to the official USP analytical assay procedure (HPLC) for estimating TAC in nasal spray forms. Furthermore, it has the potential to be implemented in routine use for rapid qualitative and quantitative determinations for TAC.
format Online
Article
Text
id pubmed-10542632
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-105426322023-10-03 Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray Alzeer, Haya S. Alzaid, Shikah F. Aldawsari, Fahad S. Alshehri, Yahya M. Saudi Pharm J Original Article A rapid, convenient, and sensitive analytical technique for quantitative analysis of triamcinolone acetonide (TAC) in pharmaceutical nasal spray dosage form using the blue tetrazolium colorimetric reaction and UV spectrophotometric method was developed and validated. Beer’s law of the developed method was proven in the concentration range of 10–40 µg/mL and showed a specific linear relationship with coefficient value R2 = 0.998. The LOQ level was 9.99 µg/mL, with (RSD = 0.26%). From precision assay, RSD values have been obtained for the repeatability and intermediate precision, which were found to be (RSD = 1.65%) and (RSD = 2.01%), respectively, indicating that the method is reproducible. Recovery studies showed mean recoveries in the range of (100.08–103.65 %), meeting the acceptance criteria for accuracy. In addition, we compared the results of the developed method UV–Vis spectrophotometric procedure with those of a well-established official USP analytical procedure (HPLC), and the results showed good agreement. The proposed UV method represents a potential alternative to the official USP analytical assay procedure (HPLC) for estimating TAC in nasal spray forms. Furthermore, it has the potential to be implemented in routine use for rapid qualitative and quantitative determinations for TAC. Elsevier 2023-10 2023-09-18 /pmc/articles/PMC10542632/ /pubmed/37791036 http://dx.doi.org/10.1016/j.jsps.2023.101793 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Alzeer, Haya S.
Alzaid, Shikah F.
Aldawsari, Fahad S.
Alshehri, Yahya M.
Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray
title Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray
title_full Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray
title_fullStr Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray
title_full_unstemmed Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray
title_short Development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray
title_sort development and validation of a simple method for the determination of triamcinolone acetonide in nasal spray
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10542632/
https://www.ncbi.nlm.nih.gov/pubmed/37791036
http://dx.doi.org/10.1016/j.jsps.2023.101793
work_keys_str_mv AT alzeerhayas developmentandvalidationofasimplemethodforthedeterminationoftriamcinoloneacetonideinnasalspray
AT alzaidshikahf developmentandvalidationofasimplemethodforthedeterminationoftriamcinoloneacetonideinnasalspray
AT aldawsarifahads developmentandvalidationofasimplemethodforthedeterminationoftriamcinoloneacetonideinnasalspray
AT alshehriyahyam developmentandvalidationofasimplemethodforthedeterminationoftriamcinoloneacetonideinnasalspray